MYM Nutraceuticals Inc, (CSE: MYM) (OTCBB: MYMMF), a Canada-based company focused on the global growth of Cannabis and CBD-rich hemp, has named its current executives, Mark Forster and Paul Cheetham, as CFO and COO respectively of MYM International Brands Inc, it is reported today.
Both executives have transferred from MYM Nutraceuticals to the International Brands team to launch global expansion efforts of CBD-rich consumer products in a wide variety of categories, including food and beverage, pharmaceuticals, cosmetics, and health and wellness.
The company has also requested one of its present independent directors, Andrew Kent, to offer assistance by serving on the board of International Brands as an independent director, and accordingly he will step down as an independent director of the company while in that new capacity.
Zydus enters exclusive talks to acquire majority stake in Amplitude Surgical
Adcendo's ADCE-T02 Phase I study IND application receives US FDA approval
WHO grants Actinogen Medical's Xanamem/UE2343 non-proprietary name 'emestedastat'
IVFMD physicians named 2025 Castle Connolly Top Doctors
HOPE Therapeutics and NRx Pharmaceuticals select BTIG as financial advisor
Partillion Bioscience opens pre-orders for Nanovial Multicell Assay Antibody Discovery Kits
Champions Oncology expands bioanalytical services with new technology
Petauri's Nicole Lodowski named to MM+M's 40 Under 40 for 2025
WuXi XDC Cayman wins 'Best CDMO' at World ADC Awards 2024
Nektar Therapeutics agrees sale of Huntsville manufacturing facility and reagent supply business